On Health Policy Archives

Calling Policy Makers

Elected officials at all levels are responsible for representing the interests of their constituents. Your elected officials must hear from you!

Concerns with the 21st Century Cures Act

This bill greatly benefits the pharmaceutical industry, medical device manufacturers, home health care companies and others. But by lowering standards for drugs and devices, it is likely to add billions to the cost of Medicare and all health programs without benefiting most patients.

Statement of NCHR President on Introduction of Prescription Drug Affordability Act of 2015

September 10, 2015. We applaud Sen. Sanders and Sen. Cummings’ bill.

NCHR Testimony at FDA on the Reauthorization of the Medical Device User Fee Act (MDUFA)

July 13, 2015. MDUFA should protect the public health by improving the safety and efficacy of all medical products, whether PMA or 510(k).

NCHR Position regarding the House of Representatives Passage of the 21st Century Cures Act

July 10, 2015. NCHR President Diana Zuckerman discusses how the 21st Century Cures Act undermines undermine scientific evidence used to approve medical products.